Company Avecho Biotechnology Limited

Equities

AVE

AU0000047441

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

Market Closed - Australian S.E. Other stock markets 02:10:55 2024-04-23 am EDT			5-day change	1st Jan Change
0.005 ^AUD	+25.00%		+25.00%	+42.86%

Mar. 25	Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial	MT
Mar. 14	Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug	MT

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

Number of employees: 15

AUD in Million	2022	Weight	2023	Weight	Delta
Production 100.0 %	1	100.0 %	0	100.0 %	-58.07%

AUD in Million	2022	Weight	Weight	Delta
Switzerland 85.2 %	1	89.4 %	85.2 %	-60.05%
Australia 8.1 %	0	2.2 %	8.1 %	+56.03%
India 6.7 %	0	2.3 %	6.7 %	+24.70%

Managers	Title	Age	Since
Paul David Gavin CEO	Chief Executive Officer	-	01-12-31
Melanie Leydin DFI	Director of Finance/CFO	51	18-12-27
Roksan Libinaki COO	Chief Operating Officer	-	00-12-31
Ross Murdoch BRD	Director/Board Member	-	15-01-13
Mahmoud El-Tamimy PRN	Corporate Officer/Principal	-	06-12-31

Members of the board	Title	Age	Since
Ross Murdoch BRD	Director/Board Member	-	15-01-13
Matthew Patrick McNamara BRD	Director/Board Member	60	20-01-12
Gregory Collier CHM	Chairman	-	15-04-12

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	3,169,297,013	2,078,984,865 ( 65.60 %)	0	65.60 %

Name	Equities	%	Valuation
Mark Kerr 7.861 %	249,133,188	7.861 %	812 174 $
Rosscope Pty Ltd. 2.698 %	85,513,129	2.698 %	278 773 $
Servbond Pty Ltd. 0.7888 %	25,000,000	0.7888 %	81 500 $
Ff Okram Pty Ltd. 0.6466 %	20,494,147	0.6466 %	66 811 $
Kazakco Pty Ltd. 0.6311 %	20,000,000	0.6311 %	65 200 $
Tony Domenic Amato 0.6153 %	19,500,712	0.6153 %	63 572 $
Churchcourt Pty Ltd. 0.5825 %	18,462,500	0.5825 %	60 188 $
Ross Graham Copeland 0.5336 %	16,912,918	0.5336 %	55 136 $
Yong Wang 0.5211 %	16,515,349	0.5211 %	53 840 $
Susan Margaret Chudleigh 0.5048 %	16,000,000	0.5048 %	52 160 $

Avecho Biotechnology Ltd.

2A Westall Road Unit A8

3168, Clayton

+61 3 9002 5000

http://www.avecho.com.au

address Avecho Biotechnology Limited(AVE)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
AVECHO BIOTECHNOLOGY LIMITED	+42.86%	8.16M
IQVIA HOLDINGS INC.	-0.02%	42.11B
LONZA GROUP AG	+46.62%	40.08B
MODERNA, INC.	+5.04%	40B
CELLTRION, INC.	-11.32%	26.87B
ICON PUBLIC LIMITED COMPANY	+5.25%	24.58B
ALNYLAM PHARMACEUTICALS, INC.	-23.83%	18.44B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.62%	11.94B
MEDPACE HOLDINGS, INC.	+22.75%	11.66B
UNITED THERAPEUTICS CORPORATION	+6.44%	11.01B

Other Biotechnology & Medical Research